{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:55:55Z","timestamp":1767920155042,"version":"3.49.0"},"update-to":[{"DOI":"10.1002\/14651858.cd004102.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:00:00Z","timestamp":1607644800000}}],"reference-count":94,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004102.pub3","type":"journal-article","created":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T14:26:33Z","timestamp":1607696793000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Trypanocidal drugs for late-stage, symptomatic Chagas disease (<i>Trypanosoma cruzi<\/i>\n infection)"],"prefix":"10.1002","volume":"2020","author":[{"given":"Maite","family":"Vallejo","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Cardiolog\u00eda Ignacio Ch\u00e1vez; Juan Badiano No. 1. Col. Seccion XVI; Tlalpan Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro PA","family":"Reyes","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Cardiolog\u00eda Ignacio Ch\u00e1vez; Juan Badiano No. 1. Col. Seccion XVI; Tlalpan Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireya","family":"Martinez Garcia","sequence":"additional","affiliation":[{"name":"Sociomedical Research Unit; Instituto Nacional de Cardiologia, Ignacio Chavez; Mexico City Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro G","family":"Gonzalez Garay","sequence":"additional","affiliation":[{"name":"Methodology Research Unit; Instituto Nacional de Pediatr\u00eda; Mexico City Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,12,11]]},"reference":[{"key":"10.1002\/14651858.CD004102.pub3-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1590\/s0037-86821997000200009","article-title":"A controlled comparative study using benznidazole, nifurtimox and placebo in chronic Chagas disease patients, in a field area with interrupted transmission: I. preliminary evaluation","volume":"30","author":"Coura","year":"1997","journal-title":"Revista da Sociedade Brasileira de Medicina Tropical"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1056\/NEJMoa1507574","article-title":"Randomized trial of benznidazole for chronic Chagas' cardiomyopathy","volume":"373","author":"Morillo","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004102.pub3-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1365-3156.2011.02936.x","article-title":"Serological profiles and evaluation of parasitaemia by PCR and blood culture in individuals chronically infected by Trypanosoma cruzi treated with benzonidazole","volume":"17","author":"Aguiar","year":"2012","journal-title":"Tropical Medicine & International Health"},{"issue":"10","key":"10.1002\/14651858.CD004102.pub3-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.trstmh.2012.07.010","article-title":"Seronegative conversion after incomplete benznidazole treatment in chronic Chagas disease","volume":"106","author":"Alvarez","year":"2012","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"833-7","DOI":"10.1128\/AAC.00745-15","article-title":"New scheme of intermittent benznidazole administration in patients chronically infected with Trypanosoma cruzi: a pilot short-term follow-up study with adult patients","volume":"60","author":"\u00c1lvarez","year":"2016","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"372-6","DOI":"10.1093\/trstmh\/trt029","article-title":"Clinical characteristics and outcome of 107 adult patients with chronic Chagas disease and parasitological cure criteria","volume":"107","author":"Bertocchi","year":"2013","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"26","key":"10.1002\/14651858.CD004102.pub3-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1056\/NEJMc1108653","article-title":"Antitrypanosomal therapy for chronic Chagas\u2019 disease","volume":"364","author":"Bestetti","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1590\/s0036-46652000000300009","article-title":"Persistent infection in chronic Chagas disease patients treated with anti-trypanosoma cruzi nitroderivatives","volume":"42","author":"Braga","year":"2000","journal-title":"Revista do Instituto de Medicina Tropical de Sao Paulo"},{"issue":"6","key":"10.1002\/14651858.CD004102.pub3-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1590\/s0037-86822011000600008","article-title":"Prevalence of Trypanosoma cruzi antibodies and inflammatory markers in uncompensated heart failure","volume":"44","author":"Bravo","year":"2011","journal-title":"Revista da Sociedade Brasileira de Medicina Tropical"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1590\/S0036-46652002000100006","article-title":"Long term evaluation of etiological treatment of Chagas disease with benznidazole","volume":"44","author":"Cancado","year":"2002","journal-title":"Revista do Instituto de Medicina Tropical de Sao Paulo"},{"issue":"1","key":"10.1002\/14651858.CD004102.pub3-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-019-3423-3","article-title":"Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial","volume":"20","author":"Villar","year":"2019","journal-title":"Trials"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1590\/s0036-46652000000200007","article-title":"Evolutive behavior towards cardiomyopathy of treated (nifurtimox or benznidazole) and untreated Chagasic patients","volume":"42","author":"Fabbro de Suasn\u00e1bar","year":"2000","journal-title":"Revista do Instituto de Medicina Tropical de Sao Paulo"},{"issue":"3-4","key":"10.1002\/14651858.CD004102.pub3-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4269\/ajtmh.2000.63.111","article-title":"Progressive chronic Chagas heart disease ten years after treatment with anti-Trypanosoma cruzi nitroderivatives","volume":"63","author":"Lauria-Pires","year":"2000","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"8","key":"10.1002\/14651858.CD004102.pub3-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1128\/CVI.00274-12","article-title":"Posttherapeutic cure criteria in Chagas' disease: conventional serology followed by supplementary serological, parasitological, and molecular tests","volume":"19","author":"Machado-de-Assis","year":"2012","journal-title":"Clinical and Vaccine Immunology"},{"issue":"1","key":"10.1002\/14651858.CD004102.pub3-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.actatropica.2012.08.020","article-title":"Towards the establishment of a consensus real-time qPCR to monitor Trypanosoma cruzi parasitaemia in patients with chronic Chagas disease cardiomyopathy: a substudy from the BENEFIT trial","volume":"125","author":"Moreira","year":"2013","journal-title":"Acta Tropica"},{"issue":"7","key":"10.1002\/14651858.CD004102.pub3-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1590\/s0074-02762010000700014","article-title":"Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease","volume":"105","author":"Moreno","year":"2010","journal-title":"Memorias do Instituto Oswaldo Cruz"},{"issue":"8","key":"10.1002\/14651858.CD004102.pub3-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1093\/jac\/dkq201","article-title":"Usefulness of PCR for monitoring benznidazole response in patients with chronic Chagas\u2019 disease: a prospective study in a non-disease-endemic country","volume":"65","author":"Murcia","year":"2010","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"7","key":"10.1002\/14651858.CD004102.pub3-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1111\/j.1469-0691.2010.03423.x","article-title":"Chagas disease in Latin American migrants: a Spanish challenge","volume":"17","author":"P\u00e9rez-Ayala","year":"2011","journal-title":"Clinical Microbiology and Infection"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0006814","article-title":"Beneficial effects of benznidazole in Chagas disease: NIH SaMi-Trop cohort study","volume":"12","author":"Cardoso","year":"2018","journal-title":"PLOS Neglected Tropical Diseases"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0020|cit20","first-page":"6","article-title":"TRENA: Treatment with benznidazole in adult patients with chronic Chagas' disease. A phase 3 randomised clinical trial (RCT) double blinded","volume":"4","author":"Riarte","year":"2015","journal-title":"Informativo. Plataforma de investigaci\u00f3n cl\u00ednica en enfermedad de Chagas"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0002-8703(94)90521-5","article-title":"Treatment of chronic Chagas' disease with benznidazole: clinical and serological evolution of patients with long-term follow-up","volume":"127","author":"Viotti","year":"1994","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"724","DOI":"10.7326\/0003-4819-144-10-200605160-00006","article-title":"Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a non-randomised trial","volume":"144","author":"Viotti","year":"2006","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0023|cit23","unstructured":"Evaluation of different benznidazole regimens for the treatment of chronic Chagas disease (MULTIBENZ) clinicaltrials.gov\/ct2\/show\/NCT03191162"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1590\/s0066-782x2011000600002","article-title":"I Latin American guidelines for the diagnosis and treatment of Chagas heart disease: executive summary","volume":"96","author":"Andrade","year":"2011","journal-title":"Arquivos Brasileiros de Cardiologia"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0025|cit25","first-page":"347","article-title":"Indeterminate form of Chagas' disease. A polymorphic disease","volume":"55","author":"Barretto","year":"1990","journal-title":"Arquivos Brasileiros de Cardiologia"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1054-3589(08)60229-X","article-title":"Chemotherapy of Trypanosoma cruzi infections","volume":"13","author":"Brener","year":"1975","journal-title":"Advances in Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD004102.pub3-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1714\/2252.24258","article-title":"What is not searched, it is difficult to find: Chagas' disease","volume":"17","author":"Briceno","year":"2016","journal-title":"Giornale Italiano di Cardiologia"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1590\/s1020-49891999000500003","article-title":"Trypanosoma cruzi infection in Triatoma infestans and other triatomines: long-term effects of a control program in rural northwestern Argentina","volume":"5","author":"Cecere","year":"1999","journal-title":"Revista Panamericana de Salud Publica [Pan American Journal of Public Health]"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1590\/S0074-02761909000200008","article-title":"New human trypanosomia. Studies on the morphology and evolutionary cycle of the Schizotrypanum cruzi n.gen., N.sp., ethiological adjunct of a new morbid entity of man","volume":"1","author":"Chagas","year":"1909","journal-title":"Memorias do Instituto Oswaldo Cruz"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0030|cit30","unstructured":"Cochrane Heart Group Preferred method for handling continuous variables www.heart.cochrane.org\/Files\/Handling%20continuous%20variables.pdf"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004102.pub3-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1590\/S0074-02761999000700069","article-title":"Chagas disease: criteria of cure and prognosis","volume":"94","author":"Contijo","year":"1999","journal-title":"Memorias do Instituto Oswaldo Cruz"},{"issue":"4","key":"10.1002\/14651858.CD004102.pub3-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1590\/s0074-02762009000400002","article-title":"Present situation and new strategies for Chagas disease chemotherapy: a proposal","volume":"104","author":"Coura","year":"2009","journal-title":"Memorias do Instituto Oswaldo Cruz"},{"issue":"9039","key":"10.1002\/14651858.CD004102.pub3-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/s0140-6736(96)04128-1","article-title":"Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection","volume":"348","author":"Andrade","year":"1996","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004102.pub3-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1590\/S0074-02762009000900007","article-title":"Elimination of Chagas disease transmission: prospectives","volume":"104","author":"Dias","year":"2009","journal-title":"Memorias do Instituto Oswaldo Cruz"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/0895-4356(92)90054-q","article-title":"Variance imputation for overviews of clinical trials with continuous response","volume":"45","author":"Follman","year":"1992","journal-title":"Journal of Clinical Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD004102.pub3-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.eimc.2013.04.024","article-title":"Paediatric Chagas in a non-endemic area","volume":"32","author":"Fumad\u00f3","year":"2014","journal-title":"Enfermedades Infecciosas y Microbiologia Clinica"},{"issue":"12","key":"10.1002\/14651858.CD004102.pub3-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"e3361","DOI":"10.1371\/journal.pntd.0003361","article-title":"Profile of Trypanosoma cruzi infection in a tropical medicine reference center, Northern Italy","volume":"8","author":"Gobbi","year":"2014","journal-title":"PLOS Neglected Tropical Diseases"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0038|cit38","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"849","DOI":"10.7326\/0003-4819-111-10-849","article-title":"Transfusion-associated acute Chagas disease acquired in the United States","volume":"111","author":"Grant","year":"1989","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/S0140-6736(05)72114-0","article-title":"Chagas' disease challenge","volume":"355","author":"Harry","year":"2000","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD004102.pub3-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"7414","key":"10.1002\/14651858.CD004102.pub3-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analysis","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0043|cit43","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"343","key":"10.1002\/14651858.CD004102.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"18","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"13","key":"10.1002\/14651858.CD004102.pub3-BIB0045|cit45","first-page":"1","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Medical Research Methodology"},{"issue":"5","key":"10.1002\/14651858.CD004102.pub3-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.parint.2015.02.005","article-title":"Chronic Chagas disease with advanced cardiac complications in Japan: case report and literature review","volume":"64","author":"Imai","year":"2015","journal-title":"Parasitology International"},{"issue":"6","key":"10.1002\/14651858.CD004102.pub3-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1021\/jm801313t","article-title":"Rational modification of a candidate cancer drug for use against Chagas disease","volume":"52","author":"Kraus","year":"2009","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1084\/jem.20020885","article-title":"A key role for old yellow enzyme in the metabolism of drugs by Tripanosoma cruzi","volume":"196","author":"Kubata","year":"2002","journal-title":"Journal of Experimental Medicine"},{"issue":"11","key":"10.1002\/14651858.CD004102.pub3-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1086\/648072","article-title":"Changes in Trypanosoma cruzi-specific immune responses after treatment: surrogate markers of treatment efficacy","volume":"49","author":"Laucella","year":"2009","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0050|cit50","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"4","DOI":"10.5772\/intechopen.86567","volume-title":"Current Topics in Neglected Tropical Diseases","author":"L\u00f3pez-Monteon","year":"2019"},{"issue":"10","key":"10.1002\/14651858.CD004102.pub3-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1517\/13543784.17.10.1427","article-title":"Benznidazole and Chagas disease: can an old drug be the answer to an old problem?","volume":"17","author":"Mady","year":"2008","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0053|cit53","first-page":"232","article-title":"Serological diagnosis of Chagas disease: self-sufficiency and interlaboratory concordance","volume":"37","author":"Monte\u00f3n","year":"1995","journal-title":"Salud Publica de Mexico"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0188-4409(99)00062-4","article-title":"American Trypanosomiasis (Chagas' disease) and blood banking in Mexico City: seroprevalence and its potential transfusional transmission risk","volume":"30","author":"Monte\u00f3n-Padilla","year":"1999","journal-title":"Archives of Medical Research"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0055|cit55","first-page":"3","article-title":"Chronic Chagas' disease: effects of treatment on the levels of antibodies to crude and partially purified Trypanosoma cruzi antigens","volume":"53","author":"Moretti","year":"1998","journal-title":"Boletin Chileno de Parasitologia"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"851","DOI":"10.7326\/0003-4819-111-10-851","article-title":"Transfusion-associeted Trypanosoma cruzi infection in a non-endemic area","volume":"111","author":"Nickerson","year":"1989","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1590\/S0074-02761989000800074","article-title":"Cost-effectiveness analysis in Chagas' disease vector's control intervention","volume":"84 (Suppl IV)","author":"Oliveira-Filho","year":"1989","journal-title":"Memorias do Instituto Oswaldo Cruz"},{"issue":"1","key":"10.1002\/14651858.CD004102.pub3-BIB0058|cit58","first-page":"22","article-title":"Cluster clinical trials","volume":"20","author":"Perman","year":"2017","journal-title":"EVIDENCIA Actualizacion en la Practica Ambulatoria"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0059|cit59","first-page":"359","article-title":"Natural history of Chagas disease","volume":"65","author":"Pinto Dias","year":"1995","journal-title":"Arquivos Brasileiros de Cardiologia"},{"issue":"6","key":"10.1002\/14651858.CD004102.pub3-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1179\/2047773212Y.0000000039","article-title":"Multicenter epidemiological and clinical study on imported Chagas diseases in Alicante, Spain","volume":"106","author":"Ramos","year":"2012","journal-title":"Pathogens and Global Health"},{"issue":"4","key":"10.1002\/14651858.CD004102.pub3-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"e2776","DOI":"10.1371\/journal.pntd.0002776","article-title":"Opportunity cost for early treatment of Chagas disease in Mexico","volume":"8","author":"Ramsey","year":"2014","journal-title":"PLOS Neglected Tropical Diseases"},{"issue":"1","key":"10.1002\/14651858.CD004102.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4269\/ajtmh.2007.76.58","article-title":"Specific treatment for Trypanosoma cruzi: lack of efficacy of allopurinol in the human chronic phase of Chagas disease","volume":"76","author":"Rassi","year":"2007","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"9723","key":"10.1002\/14651858.CD004102.pub3-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/S0140-6736(10)60061-X","article-title":"Chagas disease","volume":"375","author":"Rassi","year":"2010","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0064|cit64","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"6","key":"10.1002\/14651858.CD004102.pub3-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"e000465","DOI":"10.1371\/journal.pntd.0004656","article-title":"Trypanosoma cruzi: time for international recognition as a foodborne parasite","volume":"10","author":"Robertson","year":"2016","journal-title":"PLOS Neglected Tropical Diseases"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1590\/s0074-02762002000100001","article-title":"A critical review on Chagas disease chemotherapy","volume":"97","author":"Rodriguez-Coura","year":"2002","journal-title":"Memorias do Instituto Oswaldo Cruz"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0067|cit67","first-page":"331","article-title":"Chagas disease vector control through different intervention modalities in endemic localities of Paraguay","volume":"77","author":"Rojas","year":"1999","journal-title":"Bulletin of the World Health Organization"},{"issue":"5","key":"10.1002\/14651858.CD004102.pub3-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.4269\/ajtmh.16-0761","article-title":"Experimental and clinical treatment of Chagas disease: a review","volume":"97","author":"Sales","year":"2017","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"20","key":"10.1002\/14651858.CD004102.pub3-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.2174\/1568026616666160413125049","article-title":"Stairway to heaven or hell? Perspectives and limitations of Chagas disease chemotherapy","volume":"16","author":"Salomao","year":"2016","journal-title":"Current Topics in Medicinal Chemistry"},{"issue":"19","key":"10.1002\/14651858.CD004102.pub3-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.2174\/1568026616666160216154309","article-title":"Neglected tropical protozoan diseases: drug repositioning as a rational option","volume":"16","author":"Sbaraglini","year":"2016","journal-title":"Current Topics in Medicinal Chemistry"},{"issue":"1","key":"10.1002\/14651858.CD004102.pub3-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"e931","DOI":"10.1371\/journal.pntd.0000931","article-title":"International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients","volume":"5","author":"Schijman","year":"2011","journal-title":"PLOS Neglected Tropical Diseases"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0072|cit72","first-page":"3","volume-title":"Chagas' Disease and the Nervous System","author":"Schmunis","year":"1994"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004102.pub3-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1590\/s0074-02761999000700010","article-title":"Prevention of transfusional Trypanosoma cruzi infection in Latin America","volume":"94","author":"Schmunis","year":"1999","journal-title":"Memorias do Instituto Oswaldo Cruz"},{"issue":"4","key":"10.1002\/14651858.CD004102.pub3-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S1473-3099(13)70032-X","article-title":"Status of and cost of Chagas disease worldwide","volume":"13","author":"Schmu\u00f1is","year":"2013","journal-title":"Lancet Infectious Diseases"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0065-308x(08)60147-5","article-title":"The southern cone initiative against Chagas disease","volume":"42","author":"Schofield","year":"1999","journal-title":"Advances in Parasitology"},{"issue":"12","key":"10.1002\/14651858.CD004102.pub3-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.pt.2006.09.011","article-title":"The future of Chagas disease control","volume":"22","author":"Schofield","year":"2006","journal-title":"Trends in Parasitology"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0077|cit77","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A GRADE handbook for grading quality of evidence and strength of recommendations. The GRADE Working Group. 2013"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1590\/s0074-02761994000200017","article-title":"Reversibility of muscle and heart lesions in chronic, Trypanosoma cruzi infected mice after late trypanomicidal treatment","volume":"89","author":"Segura","year":"1994","journal-title":"Memorias do Instituto Oswaldo Cruz"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"526","DOI":"10.4269\/ajtmh.1998.59.526","article-title":"Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease","volume":"59","author":"Sosa","year":"1998","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"1119-29","DOI":"10.1016\/s0895-4356(00)00242-0","article-title":"Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature","volume":"53","author":"Sterne","year":"2000","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/bmj.323.7304.101","article-title":"Investigating and dealing with publication and other biases in meta-analysis","volume":"323","author":"Sterne","year":"2001","journal-title":"BMJ"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD004102.pub3-BIB0082|cit82","first-page":"147","article-title":"The chemotherapy of Chagas disease","volume":"59","author":"Stoppani","year":"1999","journal-title":"Medicina"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/1054-8807(92)90004-8","article-title":"Parasitic disease of the heart I: acute and chronic Chagas' disease","volume":"1","author":"Tanowitz","year":"1992","journal-title":"Cardiovascular Pathology"},{"issue":"8","key":"10.1002\/14651858.CD004102.pub3-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"e3219","DOI":"10.1371\/journal.pntd.0003219","article-title":"Chagas disease and the London declaration on neglected tropical diseases","volume":"10","author":"Tarleton","year":"2014","journal-title":"PLOS Neglected Tropical Diseases"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004102.pub3-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1590\/s0074-02761999000700068","article-title":"Parasitological cure of Chagas disease: is it possible? Is it relevant?","volume":"94","author":"Urbina","year":"1999","journal-title":"Memorias do Instituto Oswaldo Cruz"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004102.pub3-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1590\/s0074-02762009000900041","article-title":"Ergosterol biosynthesis and drug development for Chagas disease","volume":"104","author":"Urbina","year":"2009","journal-title":"Memorias do Instituto Oswaldo Cruz"},{"issue":"1","key":"10.1002\/14651858.CD004102.pub3-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/jeu.12184","article-title":"Recent clinical trials for the etiological treatment of Chronic Chagas disease: advances, challenges and perspectives","volume":"62","author":"Urbina","year":"2015","journal-title":"Journal of Eukaryotic Microbiology"},{"issue":"7","key":"10.1002\/14651858.CD004102.pub3-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.rce.2012.03.017","article-title":"A clinical and epidemiological study of the Trypanosoma cruzi infected population in the north metropolitan area of Barcelona","volume":"212","author":"Valerio-Sallent","year":"2012","journal-title":"Revista Clinica Espanola"},{"issue":"1","key":"10.1002\/14651858.CD004102.pub3-BIB0089|cit89","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003463","article-title":"Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection","author":"Villar","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD004102.pub3-BIB0090|cit90","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003463.pub2","article-title":"Trypanocidal drugs for chronic symptomatic Trypanosoma cruzi infection","author":"Villar","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0091|cit91","volume-title":"Control of Chagas' disease. Report of a WHO Expert Committee. WHO Technical Report Series No. 811","author":"World Health Organization","year":"1991"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0092|cit92","volume-title":"Investing to overcome the global impact of neglected tropical diseases: Third WHO report on neglected tropical diseases 2015","volume":"3","author":"WHO\/Department of control of neglected tropical diseases","year":"2015"},{"key":"10.1002\/14651858.CD004102.pub3-BIB0093|cit93","volume-title":"Fourth WHO report on neglected tropical diseases","volume":"1","author":"WHO\/Department of Control of Neglected Tropical Diseases","year":"2017"},{"issue":"7","key":"10.1002\/14651858.CD004102.pub3-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"e488","DOI":"10.1371\/journal.pntd.0000488","article-title":"Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Medecins Sans Fronti\u00e8res","volume":"3","author":"Yun","year":"2009","journal-title":"PLOS Neglected Tropical Diseases"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T11:00:40Z","timestamp":1650970840000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004102.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Heart Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,12,11]]},"references-count":94,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004102.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,11]]}}}